Background: There are limited studies on the risk of secondary cancers after carbon-ion radiotherapy (CIRT). We assessed the incidence of secondary cancers in patients treated with CIRT for cervical cancer. We also evaluated the incidence of secondary cancers in patients who received standard photon radiotherapy (RT) throughout the same period.Methods: This retrospective study included patients with cervical cancer who underwent curative RT at our hospital. All cancers discovered for the first time after RT were classified as secondary cancers. To compare the risk of secondary cancers among cervical cancer survivors to the general population, standardized incidence ratios (SIRs) were calculated.Results: The analysis included a total of 197 ...
One of the most common cancers in women is breast cancer. The incidence of breast cancer is great an...
To evaluate the risk of secondary primary malignancy (SPM) in patients with cervical cancer using a ...
Cervical cancer is the second most common malignancy among women worldwide ( 1). Given the 67.2 % 10...
Second cancers after uterine cervical cancer treated with radiation therapy.\nBackground: Characteri...
AbstractPurpose: Occurrence of a second cancer is the most serious event among long-term survivors a...
Background: Photon radiotherapy increases the risk of subsequent primary cancers. Carbon ion radioth...
ABSTRACT-The numbers of second cancers among 182,040 women treated for cervical cancer that were rep...
ABSTRACT-Incidence of second primary cancers was evaluated in 7,127 women with invasive cancer of th...
Background. The pattern of second cancers after treatment for cervical cancer provides important inf...
While radio-induced cancers are well known since the first years of the xxth century, they did not r...
Radiation is a treatment for many gynecological malignancies, especially locally advanced cervical c...
Previous research suggests that cervical cancer patients have a lower risk of breast cancer than wom...
The population of cancer patients with second primary malignancies (SPMs) is rapidly growing. The re...
SummaryObjectiveTo report a case of a patient with cervical squamous cell carcinoma stage IIIB who w...
PurposeSecond malignancies (SMs) after radiation therapy are rare but serious sequelae of treatment....
One of the most common cancers in women is breast cancer. The incidence of breast cancer is great an...
To evaluate the risk of secondary primary malignancy (SPM) in patients with cervical cancer using a ...
Cervical cancer is the second most common malignancy among women worldwide ( 1). Given the 67.2 % 10...
Second cancers after uterine cervical cancer treated with radiation therapy.\nBackground: Characteri...
AbstractPurpose: Occurrence of a second cancer is the most serious event among long-term survivors a...
Background: Photon radiotherapy increases the risk of subsequent primary cancers. Carbon ion radioth...
ABSTRACT-The numbers of second cancers among 182,040 women treated for cervical cancer that were rep...
ABSTRACT-Incidence of second primary cancers was evaluated in 7,127 women with invasive cancer of th...
Background. The pattern of second cancers after treatment for cervical cancer provides important inf...
While radio-induced cancers are well known since the first years of the xxth century, they did not r...
Radiation is a treatment for many gynecological malignancies, especially locally advanced cervical c...
Previous research suggests that cervical cancer patients have a lower risk of breast cancer than wom...
The population of cancer patients with second primary malignancies (SPMs) is rapidly growing. The re...
SummaryObjectiveTo report a case of a patient with cervical squamous cell carcinoma stage IIIB who w...
PurposeSecond malignancies (SMs) after radiation therapy are rare but serious sequelae of treatment....
One of the most common cancers in women is breast cancer. The incidence of breast cancer is great an...
To evaluate the risk of secondary primary malignancy (SPM) in patients with cervical cancer using a ...
Cervical cancer is the second most common malignancy among women worldwide ( 1). Given the 67.2 % 10...